Abstract:Background. It has been known that transcription factor nuclear factor (NF)-kappa B plays an important role in cell proliferation and oncogenesis. The aims of this study were to evaluate expression levels of NF-kappa B in nonsmall-cell lung cancer (NSCLC) and to elucidate its clinical significance and prognostic value for patients with NSCLC. Methods. Using 45 tumor tissue specimens from 45 patients with NSCLC who underwent surgery, we investigated the expression of NF-kappa B using Western blotting analysis. Apoptotic rate of NSCLC cells with different expression of NF-kappa B was determined by TUNEL (terminal deoxynucleotidyltransferase-mediated dUTP-biotin nick end-labeling) assay. Paraffin-embedded tissue blocks from 71 consecutive patients with NSCLC were obtained for immunohistochemical staining. Results. The expression level of NF-kappa B in poorly or moderately differentiated lung cancer cells was higher than that in well-differentiated ones (p = 0.001). The apoptotic rate was lower for lung cancer cells with higher NF-kappa B expression than for those with lower NF-kappa B expression (p = 0.0238). Furthermore, expression of NF-kappa B was correlated with caspase-3, cyclooxygenase-2, and p53 expression in lung cancer cells that were examined. Most NSCLC cells showed nuclear staining pattern and the nuclear positive rate was 67.6% (48 of 71 specimens). Immunohistochemical NF-kappa B expression in patients with NSCLC was an independent prognostic factor for overall survival. Conclusions. The results of this study suggest that expression of NF-kappa B may correlate with lung cancer differentiation. Overexpression of NF-kappa B inhibits tumor cell apoptosis and indicates an unfavorable prognosis for overall survival in some patients with NSCLC.

The Activation of NFκB in Leukemia Cells and Its Significance

Tumor Associated Gene Expression of Human Leukemia Cell Line with High Tumorigenicity in Nude Mice

Leukemia: Derived Heat Shock Protein Gp96-Peptide Complex Contribution to T Cell and Dendritic Cell Activation

Expression of Nuclear Factor-κB in Bone Marrow Cells from Patients with Acute Leukemia and Its Relationship with P21, MMP-2 and MMP-9

Inhibiton of NF-κB activity with dexamethasone enhanced apoptosis induced by chemotherapeutic drugs in human leukemic cell line

The Viral Oncogene Np9 Acts As a Critical Molecular Switch for Co-Activating Β-Catenin, ERK, Akt and Notch1 and Promoting the Growth of Human Leukemia Stem/progenitor Cells

[Relation Between Activation of NF-kappa B and Chemotherapy Induced Apoptosis of Leukemic Cells].

Expression of constitutively active nuclear-kappa B RelA transcription factor in blasts of acute myeloid leukemia

Expression of Nuclear Factor-κB and Its Clinical Significance in Nonsmall-Cell Lung Cancer

Correlation of the transcription factors IRF4 and BACH2 with the abnormal NFATC1 expression in T cells from chronic myeloid leukemia patients

Study on Activation of NK Cells by IL- 15 and GM-CSF

Cellular Origin of Ionizing Radiation‐induced NF‐κB Activationin Vivoand Role of NF‐κB in Ionizing Radiation‐induced Lymphocyte Apoptosis

Bone Marrow Stromal Cells Induced Activation of Nuclear Factor Κb Signaling Protects Non-Hodgkin’s B Lymphoma Cells from Apoptosis

Improved Quantitative Measurement Of Translocation Of Nf-Kappa B In Human Activated B Cells By Confocal Microscopy

The Nuclear Factor Kappa B (NF-kB) signaling in cancer development and immune diseases

NF‐κB signaling in inflammation and cancer

Nf-Kappa B and Its Regulation on the Immune System

Clinicopathological Implications of Nuclear Factor Κb Signal Pathway Activation in Diffuse Large B-cell Lymphoma

Experimental study on the expression of Cyclin G in leukemic mice

30 Years of NF-κB: A Blossoming of Relevance to Human Pathobiology

Cell-based Screening and Validation of Human Novel Gene TMEM9B Activated Nuclear Factor Κb Signaling Pathway*